Buy Like Buffett

The Moat Index

SBC Medical Group Holdings Incorporated

SBC · Healthcare · $315.9M mkt cap · FY2025 filings · Wide moat ·

Wonderful & reasonably priced

91/ 100
Wide moat

The four filters

Pricing power100

Median gross margin 73.3% over 3y, very stable.

Returns on capital100

Median ROIC 59.6%, above the 9% hurdle in 100% of years.

Balance-sheet safety100

Net cash position — no leverage risk.

Capital discipline56

Owner earnings +10.2%/yr, share count growing (dilution).

Margin of safety

Above valueOn sale
63% below value
Owner earnings (normalized)
$47.8M
Est. intrinsic value / share
$8.40
Recent price
$3.08
Discount to value
63% below value

Conservative model: 9% discount rate, 4% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

4 years of fundamentals

The business, in plain English

SBC Medical Group Holdings Incorporated booked $173.6M of revenue in FY2025 in the Healthcare sector and kept 73.3% of it as gross profit — a high-margin business by that measure. After every other cost, 29.4% of each revenue dollar reached the bottom line.

It earned 34.4% on invested capital in FY2025, with a median of 59.6% across 3 filed years. The Returns on Capital filter above scores it 100/100.

The balance sheet carried $42.8M of total debt in FY2025 against $52.3M of owner earnings — roughly 0.8 years of owner earnings to retire it all. Balance-Sheet Safety scores it 100/100.

Put together: Returns on Capital is the strongest of the four filters (100/100) and Capital Discipline the weakest (56/100), which is how SBC lands at 91/100 — a Wide moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2022–FY2025 · 4 fiscal years, normalized from SBC’s SEC filings

RevenueSales, as filed$173.6M FY2025
$0$100M$200M2022202320242025
Gross marginRevenue kept after cost of goods73.3% FY2025
0%50%2022202320242025
Return on invested capitalOperating profit on the capital employed34.4% FY2025
0%50%100%2022202320242025
Owner earningsCash an owner could take out$52.3M FY2025
$0$20M$40M2022202320242025

Gaps in a line mean that item isn’t in SBC’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

1 logged reading since Jul 18, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale91.0 / 100
0406080100WideNarrowShallowNo moatJul 18, 2026

Score history begins Jul 18, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — SBC has read Wide moat for every logged capture since Jul 18, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Track record

How SBC Medical Group Holdings Incorporated’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.

As-of scores 2022–2025, one methodology version · reconstructed from filings on file each Dec 31 — never with hindsight

As-of Moat Score (dot colored by tier)Indexed price (total-return (dividends reinvested))Rated Wide-moat that year

How to read this: each dot is what the engine would have scored SBC on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.

0406080100WideNarrowShallowNo moatAs-of Moat Score100Indexed price · log scale 2022202320242025

Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The indexed price path isn't available for this company yet; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.

What followed, in the years it rated Wide

In the reconstructed history shown, SBC did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.

Healthcare context

#9 of 461 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #7INVA INNOVIVA, INC.94.3Wide moat
  2. #8UTMD UTAH MEDICAL PRODUCTS INC93.1Wide moat
  3. #10TER TERADYNE, INC.90.9Wide moat
  4. #11RMD ResMed Inc.90.2Wide moat

Compare SBC with its nearest peers →All Healthcare companies on the Index →

Common questions about SBC

Does SBC Medical Group Holdings Incorporated have an economic moat?
Based on its FY2025 SEC filings, the Moat Index scores SBC Medical Group Holdings Incorporated (SBC) 91.0 out of 100 — a Wide moat. The four filters behind that score (each 0–100): pricing power 100, returns on capital 100, balance-sheet safety 100, capital discipline 56.
Is SBC stock trading below its intrinsic value?
Against a deliberately conservative owner-earnings model (9% discount rate, 4% assumed growth, capped at 4%), estimated intrinsic value is $8.40 per share versus a recent price of $3.08 — 63% below value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has SBC's Moat Score changed over time?
The record logs 1 reading since Jul 18, 2026; the latest reads 91.0 out of 100 (wide moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.
Embed this score on your site

One iframe, no script. The badge shows SBC’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/SBC"
  width="340" height="150" style="border:0"
  title="SBC Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell SBC. See the disclaimer.

SBC Medical Group Holdings Incorporated (SBC) Moat Score — The Moat Index · Buy Like Buffett